<DOC>
	<DOCNO>NCT02304497</DOCNO>
	<brief_summary>Diabetic patient may show different release growth factor microvascular complication ; retinopathy periodontitis see . Diabetes adverse effect periodontal health periodontal infection adverse effect glycemic control incidence diabetes complication . Therefore , investigator hypothesize growth factor level release platelet rich fibrin ( PRF ) diabetes mellitus ( DM ) may decrease periodontitis consider sixth microvascular complication diabetes diabetes may inductive effect PRF growth factor level periodontal disease . Determination PRF growth factor level may beneficial treatment diabetic patient periodontal disease use PRF .</brief_summary>
	<brief_title>PRF Growth Factors Levels Diabetic Patients With Chronic Periodontitis</brief_title>
	<detailed_description>The aim investigator study evaluate level platelet derive growth factor-AB ( PDGF-AB ) , vascular endothelial growth factor ( VEGF ) , transform growth factor-beta1 beta 2 ( TGF-β1 β2 ) , basic-Fibroblast growth factor ( b-FGF ) , insulin like growth factor-1 ( IGF-1 ) type 2 diabetic ( T2DM ) patient chronic periodontitis . This study consist 80 subject ; 20 patient T2DM periodontally healthy ( DM-CTRL ) , 20 patient T2DM chronic periodontitis ( DM-CP ) , 20 patient systemically healthy chronic periodontitis ( CP ; ) , 20 subject systemically periodontally healthy ( CTRL ) . Subjects clinically evaluate regard plaque index ( PI ) , gingival index ( GI ) , probe pocket depth ( PD ) , clinical attachment level ( CAL ) , bleed probe ( BOP ) record six site per tooth ( disto-facial , mid-facial , mesio-facial , mesio-lingual , disto-lingual mid-lingual ) use periodontal Goldman/Fox Williams probe calibrate millimeter . PRF prepare without biochemical manipulation blood . Intravenous blood patient collect 10 ml sterile tube without anticoagulant venipuncture antecubital vein . Immediately test tube centrifuge use centrifugation machine ( Electro.mag M 815 P Laboratory Centrifuge ; Istanbul , Turkey ) 2700 rpm ( approximately 700g ) 12 min . The centrifuged blood present structure fibrin clot middle tube red corpuscle bottom acellular plasma top . PRF easily separate red corpuscule base use steril scissors insert steril tube . The tubes put shaker agitate gently . After 5 minute , tube vortexed form PRF membrane volume releasate measure releasate return tube . The tube agitate gently . Samples take 5th minute immediately centrifuge 5000rpm 15 minute ( Electro.mag M 815 P Laboratory Centrifuge ; Istanbul , Turkey ) pellet residual blood cell , store -80 centigrade degree subsequent assay . Samples assay use enzyme-linked immunosorbent assay ( ELISA ) ELX 800 G ELISA device ( BIO-TEC Instruments , Winooski , USA ) . The following ELISA kit use study : b-FGF , TGF-β2 IGF 1 ( Assay Biotechnology Company , CA , USA ) ; PDGF-AB , VEGF TGF-β1 ( Boster Biological Technology , CA , USA ) . Statistical analysis perform use commercially available software ( SPSS 15.0 ; SPSS Inc. , Chicago , IL ) . The Shapiro-Wilk test use investigate whether data normally distribute . When normal distribution equal variance assume PDGF-AB , VEGF , TGF-β1 , variable compare use one-way analysis variance ( ANOVA ) Bonferroni post hoc test . If assumption normality fail , comparison age , TGF-β2 , b-FGF , IGF-1 , HbA1c , fast blood glucose , postprandial blood glucose , full-mouth PD , CAL , GI , PI BOP test use Kruskal-Wallis non-parametric test follow post-hoc group comparison Bonferroni-adjusted Mann-Whitney U test .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>CP patient require diagnosis moderate advance CP show radiographic evidence bone loss , define clinical attachment loss minimum 6 teeth periodontal pocket great 4 mm , minimum 20 natural teeth , No periodontal treatment prior 6 month . T2DM patient HbA1c level 6 % 8 % Periodontally healthy subject ( periodontal pocket depth &lt; 4 mm ) If know systemic disease type 2 diabetes mellitus Patient medicine treatment least 6 month except patient diabetes treat stable dos hypoglycemic agent Patients major complication DM ( i.e. , cardiovascular peripheral vascular disease Insufficient platelet count ( &lt; 200,000/mm3 ) ; 2 ) pregnancy/lactation ) Tobacco use Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Platelet rich fibrin</keyword>
	<keyword>growth factor</keyword>
</DOC>